Literature DB >> 28198635

Impact of comorbidities by age on symptom presentation for suspected acute coronary syndromes in the emergency department.

Larisa A Burke1, Anne G Rosenfeld2, Mohamud R Daya3, Karen M Vuckovic1, Jessica K Zegre-Hemsey4, Maria Felix Diaz1, Josemare Tosta Daiube Santos1, Sahereh Mirzaei1, Holli A DeVon1.   

Abstract

BACKGROUND: It is estimated half of acute coronary syndrome (ACS) patients have one or more associated comorbid conditions. AIMS: Aims were to: 1) examine the prevalence of comorbid conditions in patients presenting to the emergency department with symptoms suggestive of ACS; 2) determine if comorbid conditions influence ACS symptoms; and 3) determine if comorbid conditions predict the likelihood of receiving an ACS diagnosis.
METHODS: A total of 1064 patients admitted to five emergency departments were enrolled in this prospective study. Symptoms were measured on presentation to the emergency department. The Charlson Comorbidity Index (CCI) was used to evaluate group differences in comorbidity burden across demographic traits, risk factors, clinical presentation, and diagnosis.
RESULTS: The most prominent comorbid conditions were prior myocardial infarction, diabetes without target organ damage, and chronic lung disease. In younger ACS patients, higher CCI predicted less chest pain, chest discomfort, unusual fatigue and a lower number of symptoms. In older ACS patients, higher CCI predicted more chest discomfort, upper back pain, abrupt symptom onset, and greater symptom distress. For younger non-ACS patients, higher CCI predicted less chest pain and symptom distress. Higher CCI was associated with a greater likelihood of receiving an ACS diagnosis for younger but not older patients with suspected ACS.
CONCLUSIONS: Younger patients with ACS and higher number of comorbidities report less chest pain, putting them at higher risk for delayed diagnosis and treatment since chest pain is a hallmark symptom for ACS.

Entities:  

Keywords:  Acute coronary syndrome; age; cardiovascular conditions; comorbidities; emergency medicine; symptoms

Mesh:

Year:  2017        PMID: 28198635      PMCID: PMC5607630          DOI: 10.1177/1474515117693891

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  35 in total

1.  Classifying subgroups of patients with symptoms of acute coronary syndromes: A cluster analysis.

Authors:  Holli A DeVon; Catherine J Ryan; Sally H Rankin; Bruce A Cooper
Journal:  Res Nurs Health       Date:  2010-10       Impact factor: 2.228

Review 2.  Multiple Chronic Conditions in Older Adults with Acute Coronary Syndromes.

Authors:  Joakim Alfredsson; Karen P Alexander
Journal:  Clin Geriatr Med       Date:  2016-02-18       Impact factor: 3.076

3.  Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome.

Authors:  Juan Sanchis; Julio Núñez; Vicente Bodí; Eduardo Núñez; Ana García-Alvarez; Clara Bonanad; Ander Regueiro; Xavier Bosch; Magda Heras; Joan Sala; Oscar Bielsa; Angel Llácer
Journal:  Mayo Clin Proc       Date:  2011-02-23       Impact factor: 7.616

4.  Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study.

Authors:  David S Krantz; Marian B Olson; Jennifer L Francis; Carolyn Phankao; C Noel Bairey Merz; George Sopko; Diane A Vido; Leslee J Shaw; David S Sheps; Carl J Pepine; Karen A Matthews
Journal:  J Womens Health (Larchmt)       Date:  2006-12       Impact factor: 2.681

5.  The chest pain choice decision aid: a randomized trial.

Authors:  Erik P Hess; Meghan A Knoedler; Nilay D Shah; Jeffrey A Kline; Maggie Breslin; Megan E Branda; Laurie J Pencille; Brent R Asplin; David M Nestler; Annie T Sadosty; Ian G Stiell; Henry H Ting; Victor M Montori
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-10

6.  Development and validation of a prediction rule for early discharge of low-risk emergency department patients with potential ischemic chest pain.

Authors:  Frank Xavier Scheuermeyer; Hubert Wong; Eugenia Yu; Barb Boychuk; Grant Innes; Eric Grafstein; Kenneth Gin; Jim Christenson
Journal:  CJEM       Date:  2014-03       Impact factor: 2.410

7.  Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990-2007) and impact on death rates at 30 days and 1 year.

Authors:  David D McManus; Hoa L Nguyen; Jane S Saczynski; Mayra Tisminetzky; Peter Bourell; Robert J Goldberg
Journal:  Clin Epidemiol       Date:  2012-05-07       Impact factor: 4.790

8.  Arterial hypertension and other risk factors associated with cardiovascular diseases among adults.

Authors:  Cremilde Aparecida Trindade Radovanovic; Lucimary Afonso dos Santos; Maria Dalva de Barros Carvalho; Sonia Silva Marcon
Journal:  Rev Lat Am Enfermagem       Date:  2014 Jul-Aug

9.  Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.

Authors:  Shih-Yin Chen; Concetta Crivera; Michael Stokes; Luke Boulanger; Jeff Schein
Journal:  BMC Health Serv Res       Date:  2014-02-20       Impact factor: 2.655

10.  Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist.

Authors:  Holli A Devon; Anne Rosenfeld; Alana D Steffen; Mohamud Daya
Journal:  J Am Heart Assoc       Date:  2014-04-02       Impact factor: 5.501

View more
  2 in total

1.  Multimorbidity in Patients With Acute Coronary Syndrome Is Associated With Greater Mortality, Higher Readmission Rates, and Increased Length of Stay: A Systematic Review.

Authors:  Katherine Breen; Lorna Finnegan; Karen Vuckovic; Anne Fink; Wayne Rosamond; Holli A DeVon
Journal:  J Cardiovasc Nurs       Date:  2020 Nov/Dec       Impact factor: 2.083

2.  Preparing Chinese patients with comorbid heart disease and diabetes for home management: a mixed methods study.

Authors:  Xian-Liang Liu; Karen Willis; Chiung-Jung Jo Wu; Paul Fulbrook; Yan Shi; Maree Johnson
Journal:  BMJ Open       Date:  2019-09-17       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.